CAUTION-Investigational Device. Limited by United States Law to Investigational Use.


Studies Resources

News

Press Releases

REDUCE FMR Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation and Slows Worsening of Heart Failure September 12, 2019
Cardiac Dimensions Reaches 1,000 Implants of Carillon® System, a Minimally Invasive Treatment for Functional Mitral Regurgitation July 1, 2019
New Data Shows The Carillon Mitral Contour System® Is Associated With Improvement In Regurgitant Volume In Patients With Increased Mitral Valve Tenting June 13, 2019
New Data Confirms Cardiac Dimensions’ Carillon® System Provides Acute Hemodynamic Efficacy in Patients with Functional Mitral Regurgitation April 26, 2019
Cardiac Dimensions Appoints Carmelo Mastrandrea as Vice President of Sales January 15, 2019
Cardiac Dimensions Announces DRG Reimbursement Code for Carillon® Mitral Contour System® in Germany October 18, 2018
In Randomized Blinded Study, the Carillon Mitral Contour System Catheter-Based Treatment Meets Endpoint for Reduction in Regurgitant Volume September 24, 2018
Cardiac Dimensions Announces Late-Breaking Data to be Presented at The Transcatheter Cardiovascular Therapeutics Conference (TCT) 2018 September 20, 2018
Cardiac Dimensions Announces the Randomization of its First Patient in the U.S. Pivotal Trial – The CARILLON Trial September 19, 2018
Cardiac Dimensions Announces Appointment of Dr. Matthew Stark as Vice President of Clinical and Regulatory Affairs, Adds New Board Member May 8, 2018